EP1718607A4 - Modafinil compositions - Google Patents
Modafinil compositionsInfo
- Publication number
- EP1718607A4 EP1718607A4 EP05712282A EP05712282A EP1718607A4 EP 1718607 A4 EP1718607 A4 EP 1718607A4 EP 05712282 A EP05712282 A EP 05712282A EP 05712282 A EP05712282 A EP 05712282A EP 1718607 A4 EP1718607 A4 EP 1718607A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- modafinil compositions
- modafinil
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- YFGHCGITMMYXAQ-UHFFFAOYSA-N 2-[(diphenylmethyl)sulfinyl]acetamide Chemical compound C=1C=CC=CC=1C(S(=O)CC(=O)N)C1=CC=CC=C1 YFGHCGITMMYXAQ-UHFFFAOYSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229960001165 modafinil Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10001997A EP2292213A1 (en) | 2004-02-06 | 2005-02-01 | Compositions comprising a polymorphic form of armodafinil |
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54275204P | 2004-02-06 | 2004-02-06 | |
US56041104P | 2004-04-06 | 2004-04-06 | |
US57341204P | 2004-05-21 | 2004-05-21 | |
US57917604P | 2004-06-12 | 2004-06-12 | |
US58199204P | 2004-06-22 | 2004-06-22 | |
US58675204P | 2004-07-09 | 2004-07-09 | |
US58823604P | 2004-07-15 | 2004-07-15 | |
PCT/US2004/029013 WO2005023198A2 (en) | 2003-09-04 | 2004-09-04 | Modafinil compositions |
US63178604P | 2004-11-30 | 2004-11-30 | |
PCT/US2005/002782 WO2005077894A1 (en) | 2004-02-06 | 2005-02-01 | Modafinil compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1718607A1 EP1718607A1 (en) | 2006-11-08 |
EP1718607A4 true EP1718607A4 (en) | 2008-05-28 |
Family
ID=38456572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP05712282A Ceased EP1718607A4 (en) | 2004-02-06 | 2005-02-01 | Modafinil compositions |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1718607A4 (en) |
JP (1) | JP4917441B2 (en) |
AU (1) | AU2005212229B2 (en) |
CA (1) | CA2556106A1 (en) |
EA (1) | EA009949B1 (en) |
IL (1) | IL176934A (en) |
WO (1) | WO2005077894A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4906233B2 (en) | 2002-03-01 | 2012-03-28 | ユニバーシティー オブ サウス フロリダ | Multi-component solid phase containing at least one active pharmaceutical ingredient |
AU2003243699B2 (en) | 2002-06-21 | 2009-01-15 | Transform Pharmaceuticals, Inc. | Pharmaceutical compositions with improved dissolution |
FR2849029B1 (en) | 2002-12-20 | 2005-03-18 | Lafon Labor | PROCESS FOR THE PREPARATION AND CRYSTALLINE FORMS OF OPTICAL ENANTIOMERS OF MODAFINIL. |
US8183290B2 (en) | 2002-12-30 | 2012-05-22 | Mcneil-Ppc, Inc. | Pharmaceutically acceptable propylene glycol solvate of naproxen |
WO2005099822A2 (en) * | 2004-04-13 | 2005-10-27 | Cephalon, Inc. | Reduction of drug / drug interactions with modafinil |
EP1828098A1 (en) * | 2005-11-22 | 2007-09-05 | Teva Pharmaceutical Industries Ltd | Crystal forms of cinacalcet hci and processes for their preparation |
CN100343228C (en) * | 2006-02-17 | 2007-10-17 | 中国科学院上海有机化学研究所 | Selective prepn process of single antimer of 2-dibenzylsulfenyl-acetamide with higher antimer |
JP2009508880A (en) * | 2006-02-21 | 2009-03-05 | テバ ファーマシューティカル インダストリーズ リミティド | Novel crystal form of armodafinil and its preparation method |
EP2155664A2 (en) * | 2007-06-04 | 2010-02-24 | Generics Ýuk¨Limited | Novel process |
WO2009025791A2 (en) | 2007-08-16 | 2009-02-26 | Teva Pharmaceutical Industries Ltd. | Purification of armodafinil |
WO2009045488A2 (en) * | 2007-10-02 | 2009-04-09 | Teva Pharmaceutical Industries Ltd. | Novel crystalline forms of armodafinil and preparation thereof |
WO2009090663A1 (en) * | 2008-01-15 | 2009-07-23 | Lupin Limited | Novel crystalline polymorph of armodafinil and an improved process for preparation thereof |
KR102126389B1 (en) * | 2018-09-14 | 2020-06-25 | 셀라이온바이오메드 주식회사 | A composition for preventing or treating liver diseases comprising benzhydrylthio acetamide derivative as an active ingredient |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0233106A1 (en) * | 1986-01-31 | 1987-08-19 | Laboratoire L. Lafon | (-)-Benzhydrylsulfinylacetamide, process for its preparation and its use in therapy |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2804322B1 (en) * | 2000-01-31 | 2002-04-19 | Lafon Labor | USE OF MODAFINIL FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR CORRECTING VIGILANCE DISORDERS ASSOCIATED WITH MYOPATHIES |
KR20060097771A (en) * | 2000-07-27 | 2006-09-15 | 테바 파마슈티컬 인더스트리즈 리미티드 | Crystalline and pure modafinil, and process of preparing the same |
FR2849029B1 (en) * | 2002-12-20 | 2005-03-18 | Lafon Labor | PROCESS FOR THE PREPARATION AND CRYSTALLINE FORMS OF OPTICAL ENANTIOMERS OF MODAFINIL. |
-
2005
- 2005-02-01 EP EP05712282A patent/EP1718607A4/en not_active Ceased
- 2005-02-01 EA EA200601390A patent/EA009949B1/en not_active IP Right Cessation
- 2005-02-01 WO PCT/US2005/002782 patent/WO2005077894A1/en active Application Filing
- 2005-02-01 CA CA002556106A patent/CA2556106A1/en not_active Abandoned
- 2005-02-01 AU AU2005212229A patent/AU2005212229B2/en not_active Ceased
- 2005-02-01 JP JP2006552169A patent/JP4917441B2/en not_active Expired - Fee Related
-
2006
- 2006-07-18 IL IL176934A patent/IL176934A/en not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0233106A1 (en) * | 1986-01-31 | 1987-08-19 | Laboratoire L. Lafon | (-)-Benzhydrylsulfinylacetamide, process for its preparation and its use in therapy |
Non-Patent Citations (2)
Title |
---|
"Provigil (modafinil) tablets [C-IV]", FDA APROVED LABELING TEXT FOR NDA 20-717/S-005 & S-008, 23 January 2004 (2004-01-23), pages 1 - 35, XP002475473 * |
See also references of WO2005077894A1 * |
Also Published As
Publication number | Publication date |
---|---|
JP4917441B2 (en) | 2012-04-18 |
AU2005212229B2 (en) | 2011-06-09 |
IL176934A0 (en) | 2006-12-10 |
EP1718607A1 (en) | 2006-11-08 |
WO2005077894A1 (en) | 2005-08-25 |
CA2556106A1 (en) | 2005-08-25 |
EA200601390A1 (en) | 2006-12-29 |
AU2005212229A1 (en) | 2005-08-25 |
EA009949B1 (en) | 2008-04-28 |
IL176934A (en) | 2013-06-27 |
JP2007522147A (en) | 2007-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1718714A4 (en) | Tracer-containing compositions | |
IL176934A0 (en) | Modafinil compositions | |
ZA200904425B (en) | Nemathical compositions | |
GB0409375D0 (en) | Phytoactive composition | |
EP1726304A4 (en) | Solifenacin-containing composition | |
GB0405406D0 (en) | Anti-vaginitis compositions | |
GB0425795D0 (en) | Composition | |
GB0410038D0 (en) | Composition | |
GB0416861D0 (en) | Composition | |
GB0414803D0 (en) | Composition | |
ZA200704974B (en) | Composition | |
GB0415981D0 (en) | Composition | |
GB0417357D0 (en) | Composition | |
ZA200701197B (en) | Compositions | |
GB0410140D0 (en) | Compositions | |
IL173575A0 (en) | Modafinil compositions | |
GB0420627D0 (en) | Monoglyceride-containing compositions | |
GB0425445D0 (en) | Novel compositions | |
GB0417388D0 (en) | Composition | |
GB2418924B (en) | Weathered-effect composition | |
ZA200606337B (en) | Modafinil compositions | |
GB0409598D0 (en) | Composition | |
GB0412304D0 (en) | Compositions | |
GB0412544D0 (en) | Compositions | |
GB0412039D0 (en) | Compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20060831 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR LV MK YU |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1096381 Country of ref document: HK |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/165 20060101ALI20080416BHEP Ipc: C07C 315/06 20060101ALI20080416BHEP Ipc: C07C 317/48 20060101AFI20080416BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20080428 |
|
17Q | First examination report despatched |
Effective date: 20080910 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20100517 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1096381 Country of ref document: HK |